Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03585530
What this trial is testing

Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus

Who this might be right for
Esophagus Squamous Cell Carcinoma
Huai'an First People's Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT05252078
What this trial is testing

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsEsophageal Diseases+8 more
Jiangxi Provincial Cancer Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04390958
What this trial is testing

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Chinese Academy of Medical Sciences 70
Testing effectiveness (Phase 2)WithdrawnNCT04625543
What this trial is testing

Neoadjuvant Immunotherapy to ESCC

Who this might be right for
Esophagus SCC
Qilu Hospital of Shandong University
Not applicableStudy completedNCT02534233
What this trial is testing

Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium

Who this might be right for
Barrett's EsophagusEsophageal Squamous DysplasiaEsophageal Cancer
Johns Hopkins University 58
Testing effectiveness (Phase 2)Study completedNCT00397904
What this trial is testing

Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)UnknownNCT01267578
What this trial is testing

Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)

Who this might be right for
Esophageal Cancer
University of Yamanashi 60
Large-scale testing (Phase 3)UnknownNCT03273647
What this trial is testing

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin

Who this might be right for
Esophageal Squamous Cell CarcinomaPositive Circumferential Resection Margin
Fudan University 60
Testing effectiveness (Phase 2)UnknownNCT04506138
What this trial is testing

Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 46
Large-scale testing (Phase 3)UnknownNCT02570893
What this trial is testing

A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Zhejiang Cancer Hospital 366
Large-scale testing (Phase 3)Looking for participantsNCT04460352
What this trial is testing

Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Karolinska University Hospital 1,020
Testing effectiveness (Phase 2)Study completedNCT01854749
What this trial is testing

S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 57
Not applicableActive Not RecruitingNCT07702253
What this trial is testing

O-GlcNAcylation Induced HMGB1 Signalling

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Chinese University of Hong Kong 120
Testing effectiveness (Phase 2)Looking for participantsNCT06410651
What this trial is testing

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerNimotuzumabChemoradiotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 53
Not applicableActive Not RecruitingNCT03712566
What this trial is testing

Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy

Who this might be right for
CancerEsophagus Squamous Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+2 more
University Health Network, Toronto 39
Large-scale testing (Phase 3)Study completedNCT02399306
What this trial is testing

Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEnteral Nutrition TherapyChemoradiotherapy
Sichuan Cancer Hospital and Research Institute 222
Testing effectiveness (Phase 2)Looking for participantsNCT07700667
What this trial is testing

SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Post-approval studies (Phase 4)Study completedNCT02721563
What this trial is testing

A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

Who this might be right for
Esophageal Neoplasms
Shandong Cancer Hospital and Institute 77
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06690216
What this trial is testing

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

Who this might be right for
Glioblastoma (GBM)Head and Neck Squamous Cell CarcinomaNon-Small Cell Lung Cancer+1 more
Man Hu 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876
What this trial is testing

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

Who this might be right for
MSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more
SOLTI Breast Cancer Research Group 184
Next Page